Atlas Molecular Pharma closed a €3 million deal led by Inveready, joined by CDTI, Grupo SPRI, Kereon Partners, Endometrial DIDI, and CRB Inverbio
04 January 2026
04 January 2026
Total investments received (USD): 6.87M
Round value (USD): 3.47M
Company: Atlas Molecular Pharma
Related deals
Adaptam Therapeutics raised a €3 million pre-seed financing round led by Criteria Bio Ventures.
Investments
13 October 2025
Neuronoff raised $4.5 million
Investments
02 October 2025
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom